MedPath

DESLORATADINE

These highlights do not include all the information needed to use DESLORATADINE TABLETS safely and effectively. See full prescribing information for DESLORATADINE TABLETS. DESLORATADINE tablets for oral use Initial U.S. Approval: 2001

Approved
Approval ID

2a90b899-7746-43dc-ac8a-e754428eb30c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 19, 2024

Manufacturers
FDA

Lupin Pharmaceuticals, Inc.

DUNS: 089153071

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

DESLORATADINE

PRODUCT DETAILS

NDC Product Code68180-153
Application NumberANDA078352
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateJanuary 19, 2024
Generic NameDESLORATADINE

INGREDIENTS (1)

DESLORATADINEActive
Quantity: 5 mg in 1 1
Code: FVF865388R
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.